AOA体育相关的文章
Related Articles详细介绍
品牌 | 其他品牌 | 供货周期 | 现货 |
---|---|---|---|
应用领域 | 医疗卫生,环保,食品,化工,生物产业 |
Biovisoin代理销售 2218-250
Biovisoin代理销售 2218-250
2218-250 | Retinoic acid |
2219-10 | Auranofin |
2219-50 | Auranofin |
2220-1 | I-BET151 |
2220-5 | I-BET151 |
2222-1 | BI 6727 |
2222-5 | BI 6727 |
2224-5 | Lomeguatrib |
2224-25 | Lomeguatrib |
2225-1 | Zebularine |
2225-5 | Zebularine |
2226-10 | Temozolomide |
2226-50 | Temozolomide |
2227-1 | Smad3 Inhibitor, SIS3 |
2227-5 | Smad3 Inhibitor, SIS3 |
2228-1 | Necrosis Inhibitor, Necrox-2 |
2228-5 | Necrosis Inhibitor, Necrox-2 |
2229-1 | Necrosis Inhibitor, Necrox-5 |
2229-5 | Necrosis Inhibitor, Necrox-5 |
2230-5 | Ferrostatin-1 |
2230-25 | Ferrostatin-1 |
2231-1 | Erastin |
2231-5 | Erastin |
2232-10 | Docetaxel |
2232-50 | Docetaxel |
2234-5 | AZD6244 |
2234-25 | AZD6244 |
2235-5 | PLX-4032 |
2235-25 | PLX-4032 |
2236-5 | Clofarabine |
2236-25 | Clofarabine |
2237-50 | Rasagiline mesylate |
2237-250 | Rasagiline mesylate |
2238-10 | Valinomycin |
2238-50 | Valinomycin |
2239-10 | Combretastatin A4 |
2239-50 | Combretastatin A4 |
2240-50 | Linagliptin |
2240-250 | Linagliptin |
2241-50 | Lopinavir |
2241-250 | Lopinavir |
2242-5 | BAPTA AM |
2242-25 | BAPTA AM |
2243-1 | FURA-2 Am |
2243-1EA | FURA-2 Am |
2245-1 | A-23187, 4-Bromo |
2246-10 | Bleomycin sulfate |
2246-50 | Bleomycin sulfate |
2247-10 | Antimycin A |
2247-50 | Antimycin A |
2248-250 | Rotenone |
2248-1000 | Rotenone |
2249-25 | 3-Methyladenine |
2249-100 | 3-Methyladenine |
2250-1 | Oxamflatin |
2250-5 | Oxamflatin |
2251-5 | PCI 34051 |
2251-25 | PCI 34051 |
2252-1 | UNC 1215 |
2252-5 | UNC 1215 |
2253-1 | BCl-2 Inhibitor, ABT-199 |
2253-5 | BCl-2 Inhibitor, ABT-199 |
2254-5 | MEK-162 |
2254-25 | MEK-162 |
2255-500 | mTOR Inhibitor, WYE-28 |
2255-1000 | mTOR Inhibitor, WYE-28 |
2256-500 | mTOR Inhibitor, WYE-132 |
2256-1000 | mTOR Inhibitor, WYE-132 |
2257-500 | mTOR Inhibitor, WYE-23 |
2257-1000 | mTOR Inhibitor, WYE-23 |
2258-5 | Xanthohumol |
2258-25 | Xanthohumol |
2259-1 | GSK-J4 hydrochloride |
2259-5 | GSK-J4 hydrochloride |
2260-1 | GSK-J1 sodium salt |
2260-5 | GSK-J1 sodium salt |
2261-1 | Chidamide |
2261-5 | Chidamide |
2262-5 | β-Lapachone |
2262-25 | β-Lapachone |
2263-1 | Nec-1s |
2263-5 | Nec-1s |
2264-5 | KY02111 |
2264-25 | KY02111 |
2265-5 | EHNA hydrochloride |
2265-25 | EHNA hydrochloride |
2266-5 | IOX1 |
2266-25 | IOX1 |
2267-5 | ML141 |
2267-25 | ML141 |
2268-5 | Prostaglandin E2 |
2268-25 | Prostaglandin E2 |
2269-100 | L-Ascorbic acid |
2269-1000 | L-Ascorbic acid |
2270-5 | Pifithrin-α, Cyclic, hydrobromide |
2271-1 | EZSolution™ Trichostatin A |
2272-5 | GSK-690693 |
2272-25 | GSK-690693 |
2273-5 | Torin 1 |
2273-25 | Torin 1 |
2274-5 | Torin 2 |
2274-25 | Torin 2 |
2275-5 | ICG-001 |
2275-25 | ICG-001 |
2276-50 | KT5720 |
2276-100 | KT5720 |
2277-5 | P5091 |
2277-25 | P5091 |
2278-10 | Atorvastatin |
2278-50 | Atorvastatin |
2279-5 | Kainic acid |
2279-25 | Kainic acid |
2280-5 | Delamanid |
2280-25 | Delamanid |
2281-1 | GSK343 |
2281-5 | GSK343 |
2282-1 | GSK126 |
2282-5 | GSK126 |
2283-500 | Chaetocin |
2284-5 | CBHA |
2284-10 | CBHA |
2285-1 | SB 939 |
2285-5 | SB 939 |
2286-5 | GSK1904529A |
2286-25 | GSK1904529A |
2287-5 | GSK461364 |
2287-25 | GSK461364 |
2288-5 | GSK1349572 |
2288-25 | GSK1349572 |
2289-5 | PF-04691502 |
2289-25 | PF-04691502 |
2290-50 | Plumbagin |
2290-250 | Plumbagin |
2291-5 | BIIB 021 |
2291-25 | BIIB 021 |
2292-5 | 680C91 |
2292-25 | 680C91 |
2293-10 | Castanospermine |
2293-50 | Castanospermine |
2294-5 | Linsitinib, Free base |
2294-25 | Linsitinib, Free base |
2295-5 | OSU-03012 |
2295-25 | OSU-03012 |
2296-1 | Tipifarnib, Free base |
2296-5 | Tipifarnib, Free base |
2297-5 | LY573636 |
2297-25 | LY573636 |
2298-5 | BTK Inhibitor, PCI-32765 |
2298-25 | BTK Inhibitor, PCI-32765 |
2299-5 | LY2886721 |
2299-25 | LY2886721 |
2300-50 | AMI-5 |
2300-250 | AMI-5 |
2301-5 | USP7/USP47 Inhibitor, P 22077 |
2301-25 | USP7/USP47 Inhibitor, P 22077 |
2302-5 | DUB Inhibitor, PR-619 |
2302-25 | DUB Inhibitor, PR-619 |
2303-50 | Caffeic acid |
2303-250 | Caffeic acid |
2304-100 | HDM Inhibitor, 2,4-PDCA |
2304-500 | HDM Inhibitor, 2,4-PDCA |
2305-50 | 5-Methylcytosine hydrochloride |
2305-250 | 5-Methylcytosine hydrochloride |
2306-50 | 5-Methylcytidine |
2306-250 | 5-Methylcytidine |
2307-1 | Tripolin A |
2307-5 | Tripolin A |
2308-50 | Disulfiram |
2308-250 | Disulfiram |
2309-5 | EZSolution™ Ionomycin free acid |
2310-5 | YM155 |
2310-25 | YM155 |
2311-250 | Prodigiosin |
2311-1000 | Prodigiosin |
2312-1 | Sauchinone |
2312-5 | Sauchinone |
2313-1 | NU6102 |
2313-5 | NU6102 |
2314-1 | TG101348 |
2314-5 | TG101348 |
2315-1 | AZD1480 |
2315-5 | AZD1480 |
2316-1 | Cyt387 |
2316-5 | Cyt387 |
2317-1 | Aurodox |
2318-5 | Imperatorin |
2318-25 | Imperatorin |
2319-1 | PJ-34 hydrochloride |
2319-5 | PJ-34 hydrochloride |
2320-50 | Sulfo-SMCC |
2320-100 | Sulfo-SMCC |
2320-1000 | Sulfo-SMCC |
2320-1EA | Sulfo-SMCC |
2321-500 | Sulfo-NHS |
2321-5G | Sulfo-NHS |
2321-1 EA | Sulfo-NHS |
2322-50 | Sulfo-NHS-Biotin |
2322-250 | Sulfo-NHS-Biotin |
2322-1EA | Sulfo-NHS-Biotin |
2323-50 | Sulfo-NHS-SS-Biotin |
2323-100 | Sulfo-NHS-SS-Biotin |
2323-1EA | Sulfo-NHS-SS-Biotin |
2324-50 | Sulfo-SANPAH |
2324-250 | Sulfo-SANPAH |
2325-50 | Sulfo-LC-SPDP |
2325-250 | Sulfo-LC-SPDP |
2326-50 | Sulfo-NHS-LC-Biotin |
2326-100 | Sulfo-NHS-LC-Biotin |
2326-1EA | Sulfo-NHS-LC-Biotin |
2327-50 | BS3 Crosslinker |
2327-250 | BS3 Crosslinker |
2327-1000 | BS3 Crosslinker |
2327-1EA | BS3 Crosslinker |
2328-50 | SPDP Crosslinker |
2328-250 | SPDP Crosslinker |
2329-50 | Biotin-HPDP |
2329-250 | Biotin-HPDP |
2330-500 | Traut's Reagent |
2330-1000 | Traut's Reagent |
2331-5G | N-Hydroxysuccinimide |
2331-25G | N-Hydroxysuccinimide |
2332-5 | Laquinimod |
2332-25 | Laquinimod |
2333-1 | Manumycin A |
2333-5 | Manumycin A |
2334-250 | Sclerotiorin |
2334-1000 | Sclerotiorin |
2335-5 | Miglitol |
2335-25 | Miglitol |
2336-10 | Amlexanox |
2336-50 | Amlexanox |
2337-50 | DTSSP Crosslinker |
2337-250 | DTSSP Crosslinker |
2338-1 | Akt Inhibitor (10-NCP) |
2338-5 | Akt Inhibitor (10-NCP) |
2339-1 | AS 604850 |
2339-5 | AS 604850 |
2340-1 | AZD8055 |
2340-5 | AZD8055 |
2341-1 | AMPK Activator, D942 |
2341-5 | AMPK Activator, D942 |
2342-5 | ROCK Inhibitor (Rockout) |
2342-25 | ROCK Inhibitor (Rockout) |
2343-5 | SKPin C1 |
2343-25 | SKPin C1 |
2344-50 | EZSolution™ AICAR |
2345-50 | Biotin-LC-NHS |
2345-250 | Biotin-LC-NHS |
2345-1000 | Biotin-LC-NHS |
2346-50 | Biotin-LC-LC-NHS |
2346-250 | Biotin-LC-LC-NHS |
2346-1000 | Biotin-LC-LC-NHS |
2347-50 | Biotin-NHS |
2347-250 | Biotin-NHS |
2347-1000 | Biotin-NHS |
2348-5 | L-NMMA acetate |
2348-25 | L-NMMA acetate |
2348-100 | L-NMMA acetate |
2349-1 | IWP-3 |
2349-5 | IWP-3 |
2350-5 | KH7 |
2350-25 | KH7 |
2351-1 | NU 1025 |
2351-5 | NU 1025 |
2352-5 | Apremilast |
2352-25 | Apremilast |
2353-5 | EZSolution™ Torin 1 |
2354-5 | EZSolution™ Torin 2 |
2355-25 | EZSolution™ Tetrahydrouridine |
2356-100 | L-NAME hydrochloride |
2356-500 | L-NAME hydrochloride |
2356-1000 | L-NAME hydrochloride |
2357-1 | Jervine |
2357-5 | Jervine |
2358-5 | Diphenyleneiodonium chloride |
2359-1 | BEC |
2359-5 | BEC |
2360-50 | 7-Nitroindazole |
2360-250 | 7-Nitroindazole |
2361-10 | 3-Bromo-7-nitroindazole |
2361-50 | 3-Bromo-7-nitroindazole |
2362-50 | Norquetiapine dihydrochloride |
2362-250 | Norquetiapine dihydrochloride |
2363-100 | SATA |
2363-250 | SATA |
2363-1000 | SATA |
2364-2 | EZH2 Inhibitor, EPZ005687 |
2364-10 | EZH2 Inhibitor, EPZ005687 |
2365-1 | EZSolution™ GSK343 |
2366-1 | EZSolution™ GSK126 |
2367-250 | Borrelidin |
2367-1000 | Borrelidin |
2368-1 | Fumagillin |
2369-1 | AGI-5198 |
2369-5 | AGI-5198 |
2370-5 | BI-2536 |
2370-25 | BI-2536 |
2371-5 | AZD-3463 |
2371-25 | AZD-3463 |
2372-5 | OSI-027 |
2372-25 | OSI-027 |
2373-5 | MK-1775 |
2373-25 | MK-1775 |
2374-50 | Gossypin |
2374-250 | Gossypin |
2375-2 | EZSolution™ EPZ005687 |
2376-5 | AG-1296 |
2377-10 | Amifostine |
2377-50 | Amifostine |
2378-50 | Amlodipine besylate |
2378-250 | Amlodipine besylate |
2379-5 | BML-278 |
2379-25 | BML-278 |
2380-5 | AT-101 |
2380-25 | AT-101 |
2381-1 | EPZ004777 |
2381-5 | EPZ004777 |
2382-1 | EPZ-5676 |
2382-5 | EPZ-5676 |
2383-5 | EPZ-6438 |
2383-25 | EPZ-6438 |
2384-1 | (-)-JQ1 |
2385-5 | Carfilzomib |
2385-25 | Carfilzomib |
2386-5 | Oprozomib |
2386-25 | Oprozomib |
2387-50 | 2'-Deoxy-5-fluorocytidine |
2387-250 | 2'-Deoxy-5-fluorocytidine |
2388-5 | Nitrocefin |
2388-25 | Nitrocefin |
2389-50 | Andrographolide |
2389-250 | Andrographolide |
2390-5 | C2 Ceramide |
2390-25 | C2 Ceramide |
2391-5 | C2-Dihydroceramide |
2391-25 | C2-Dihydroceramide |
2392-5 | MMP-13 inhibitor |
2392-25 | MMP-13 inhibitor |
2393-5 | Cilostazol |
2393-25 | Cilostazol |
2394-10 | CENTA β-lactamase substrate |
2394-50 | CENTA β-lactamase substrate |
2395-5 | HDAC Substrate II, Colorimetric |
2395-25 | HDAC Substrate II, Colorimetric |
2396-5 | HDAC Substrate, Fluorogenic |
2396-25 | HDAC Substrate, Fluorogenic |
2397-5 | Epalrestat |
2397-25 | Epalrestat |
2398-5 | FCCP |
2398-25 | FCCP |
2399-10 | Felodipine |
2399-50 | Felodipine |
2400-5 | GSK-3787 |
2400-25 | GSK-3787 |
2403-5 | AKR1C3 Inhibitor I |
2403-25 | AKR1C3 Inhibitor I |
2404-5 | AKR1C3 Inhibitor II |
2404-25 | AKR1C3 Inhibitor II |
2405-5 | (±)-Blebbistatin |
2405-25 | (±)-Blebbistatin |
2406-1 | (-)-Blebbistatin |
2406-5 | (-)-Blebbistatin |
2407-1 | (+)-Blebbistatin |
2407-5 | (+)-Blebbistatin |
2408-100 | L-Selenomethionine |
2408-500 | L-Selenomethionine |
2408-1000 | L-Selenomethionine |
2409-1 | EZSolution™ 3-Deazaneplanocin A |
2410-5 | HPI-1 |
2410-25 | HPI-1 |
2411-1 | 24(S)-Hydroxycholesterol |
2412-5 | GW-5074 |
2412-25 | GW-5074 |
2413-5 | JNJ-1661010 |
2413-25 | JNJ-1661010 |
2414-5 | LFM-A13 |
2414-25 | LFM-A13 |
2415-10 | 1,5-Isoquinolinediol |
2415-50 | 1,5-Isoquinolinediol |
2416-100 | Phlorizin |
2416-500 | Phlorizin |
2417-1 | GW 4869 dihydrocloride |
2417-5 | GW 4869 dihydrocloride |
2418-1 | Anacetrapib |
2418-5 | Anacetrapib |
2419-1 | Dalcetrapib |
2419-5 | Dalcetrapib |
2420-5 | Torcetrapib |
2420-25 | Torcetrapib |
2421-50 | Mambalgin-1 |
2421-100 | Mambalgin-1 |
2422-5 | Veratridine |
2422-25 | Veratridine |
2423-10 | Aconitine |
2423-50 | Aconitine |
2424-5 | AKR1C3 Inhibitor III |
2424-25 | AKR1C3 Inhibitor III |
2425-5 | D-erythro-Sphingosine |
2425-25 | D-erythro-Sphingosine |
2426-50 | Phytosphingosine |
2426-250 | Phytosphingosine |
2427-1 | EZSolution™ EPZ-5676 |
2428-5 | EZSolution™ EPZ-6438 |
2429-5 | Cryptotanshinone |
2429-25 | Cryptotanshinone |
2430-1 | Semagacestat |
2430-5 | Semagacestat |
2431-5 | TPCA-1 |
2431-25 | TPCA-1 |
2432-5 | AT9283 |
2432-25 | AT9283 |
2433-5 | CEP-18770 |
2433-25 | CEP-18770 |
2434-200 | Lactacystin (Natural) |
2435-100 | cGAMP disodium salt |
2436-5 | Quinol 1h |
2436-25 | Quinol 1h |
2437-5 | Quinol 2 |
2437-25 | Quinol 2 |
2438-100 | Daminozide |
2438-500 | Daminozide |
2439-1 | Eptifibatide |
2440-1 | Enfuvirtide Acetate |
2441-5 | Mdivi -1 |
2441-25 | Mdivi -1 |
2442-5 | SC-514 |
2442-25 | SC-514 |
2443-100 | 1-Methyl-4-vinylpyridinium triflate |
2443-500 | 1-Methyl-4-vinylpyridinium triflate |
2444-250 | 3-Deazaneplanocin A hydrochloride |
2444-1000 | 3-Deazaneplanocin A hydrochloride |
2445-5 | IPI-145 |
2445-25 | IPI-145 |
2446-5 | SNS-314 |
2446-25 | SNS-314 |
2447-1 | FK228 |
2448-5 | SGC0946 |
2448-25 | SGC0946 |
2449-5 | UNC1999 |
2449-25 | UNC1999 |
2450-1 | SB1518 (Pacritinib) |
2450-5 | SB1518 (Pacritinib) |
2451-5 | BAX Activator, BAM7 |
2451-25 | BAX Activator, BAM7 |
2452-1 | BAY 58-2667 (Free base) |
2452-5 | BAY 58-2667 (Free base) |
2454-1G | Clioquinol |
2454-5G | Clioquinol |
2455-5 | BMS-777607 |
2455-25 | BMS-777607 |
产品咨询
电话
微信扫一扫